Company: INSP
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001609550-25-000053
Chunk: 69

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 8
Chunk 69
---
111 150 (14)36,247 Long-term investments$88,088 $289 $(24)$88,353 December 31, 2024AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term:Commercial paper$19,806 $25 $— $19,831 Corporate debt securities47,226 80 (7)47,299 Certificates of deposit7,684 10 — 7,694 U.S. treasury debt securities220,283 346 (57)220,572 Short-term investments$294,999 $461 $(64)$295,396 Long-Term:Corporate debt securities$23,915 $59 $(49)$23,925 Asset-backed securities287 — — 287 U.S. treasury debt securities46,818 50 (85)46,783 Long-term investments$71,020 $109 $(134)$70,995 The following table shows all available-for-sale investments in an unrealized loss position for which an allowance for credit losses has not been recorded and the related gross unrealized loss and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:

11

Table of ContentsInspire Medical Systems, Inc. Notes to Consolidated Financial Statements (unaudited) (Table amounts in thousands, except share and per share amounts)

September 30, 2025Less than 12 Months12 Months or GreaterTotalFair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized LossCorporate debt securities$16,455 $(12)$— $— $16,455 $(12)U.S. Treasury debt securities30,000 (21)16,003 (10)46,003 (31)Total$46,455 $(33)$16,003 $(10)$62,458 $(43)December 31, 2024Less than 12 Months12 Months or GreaterTotalFair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized LossCorporate debt securities$11,728 $(56)$— $— $11,728 $(56)U.S. Treasury debt securities69,402 (220)— — 69,402 (220)Total$81,130 $(276)$— $— $